Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson full-time equivalent (FTE) positions (Form 10-K)
Form 10-K Item 1 (Human Capital Management)
Latest, FY2025
138,200
Period ended Dec 28, 2025
Change on a year earlier
+0.1%
138,100 in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Full-time equivalent (FTE) positions (Form 10-K) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 138,200 | +0.1% | Form 10-K (jnj-20251228.htm, filed 2026-02-11) ↗ |
| FY2024 | Dec 29, 2024 | 138,100 | +4.7% | Form 10-K (jnj-20251228.htm, filed 2026-02-11) ↗ |
| FY2023 | Dec 31, 2023 | 131,900 | -13.6% | Form 10-K (jnj-20241229.htm, filed 2025-02-13) ↗ |
| FY2022 | Jan 1, 2023 | 152,700 | +7.8% | Form 10-K (jnj-20230101.htm, filed 2023-02-16) ↗ |
| FY2021 | Jan 2, 2022 | 141,700 | +5.4% | Form 10-K (jnj-20230101.htm, filed 2023-02-16) ↗ |
| FY2020 | Jan 3, 2021 | 134,500 | +1.7% | Form 10-K (jnj-20220102.htm, filed 2022-02-17) ↗ |
| FY2019 | Dec 29, 2019 | 132,200 | – | Form 10-K (jnj-20210103.htm, filed 2021-02-22) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson Full-time equivalent (FTE) positions (Form 10-K), annual FY2019–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/emp_fte_10k
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.